Resultado da Busca
Janet Woodcock (born August 29, 1948) is an American physician serving as Principal Deputy Commissioner of Food and Drugs, having previously served as Acting Commissioner of the U.S. Food and Drug Administration (FDA).
17 de fev. de 2022 · Janet Woodcock is the FDA’s Principal Deputy Commissioner. In this role she works closely with the Commissioner of Food and Drugs to develop and implement key public health initiatives...
- Principal Deputy Commissioner
- Office of The Commissioner
16 de nov. de 2023 · U.S. Food and Drug Administration (FDA) Principal Deputy Commissioner Dr. Janet Woodcock, who led the regulator during the height of the COVID-19 pandemic as acting chief, plans to retire early...
16 de nov. de 2023 · US Food and Drug Administration Deputy Commissioner Janet Woodcock will retire next year after nearly four decades at the regulator that were marked by controversy over support for unproven...
17 de nov. de 2023 · The principal deputy commissioner of the Food and Drug Administration announced her plans to step down from her post after nearly four decades of service. News outlets look back at her record of overseeing the approval of biotechnology-based treatments, drug regulation and Covid-19 response.
30 de jan. de 2024 · Janet Woodcock, the FDA's principal deputy commissioner, reflects on her more than 30 years at the agency and hints at what's next. She oversaw hundreds of drug reviews, faced Covid-19 challenges and a reorganization plan.
16 de nov. de 2023 · US Food and Drug Administration Deputy Commissioner Janet Woodcock will retire next year after nearly four decades at the regulator that were marked by controversy over support for unproven medications for rare, serious conditions. Woodcock confirmed the news in an email.
